CURAGEN CORP
10-Q, EX-27, 2000-08-09
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CURAGEN CORP, 10-Q, EX-11, 2000-08-09
Next: FIRSTENERGY CORP, 425, 2000-08-09



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                     254,191,435
<SECURITIES>                                         0
<RECEIVABLES>                                  126,206
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           256,020,812
<PP&E>                                      23,122,264
<DEPRECIATION>                               8,999,417
<TOTAL-ASSETS>                             275,474,274
<CURRENT-LIABILITIES>                       14,508,334
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       386,265
<OTHER-SE>                                  88,166,370
<TOTAL-LIABILITY-AND-EQUITY>               275,474,274
<SALES>                                              0
<TOTAL-REVENUES>                            10,579,555
<CGS>                                                0
<TOTAL-COSTS>                               15,856,973
<OTHER-EXPENSES>                             7,704,032
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                           (11,652,347)
<INCOME-TAX>                                   350,000
<INCOME-CONTINUING>                       (11,320,582)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (11,320,582)
<EPS-BASIC>                                    ($0.30)
<EPS-DILUTED>                                  ($0.30)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission